Market Size of Europe Healthcare Cold Chain Logistics Industry
| Study Period | 2020-2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 10.40 Billion |
| Market Size (2029) | USD 16.39 Billion |
| CAGR (2024 - 2029) | 9.69 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Healthcare Cold Chain Logistics Market Analysis
The Europe Healthcare Cold Chain Logistics Market size is estimated at USD 10.40 billion in 2024, and is expected to reach USD 16.39 billion by 2029, growing at a CAGR of 9.69% during the forecast period (2024-2029).
A surge in the development and production of biopharmaceutical vaccines and advanced therapies, technological advancement, and the region's interest in R&D have contributed significantly to the market's growth.
During the COVID-19 pandemic, the pharmaceutical industry was one of the most affected sectors, witnessing increased production and supply of vaccines and antidotes worldwide. The United States Department of Transport selected 41 projects to receive around USD 653 million in grants under the Port Infrastructure Development Programme for infrastructure spending for ports and waterways in 2021. Improved temperature-controlled storage facilities at ports for pharmaceutical and other medical products, which require special temperature conditions throughout their journey, were crucial.
The European Medical Agency approves an average of 38 drugs annually, depicting an increase in the development of biopharmaceuticals. The growth in the biopharmaceuticals sector demands advanced requirements for the storage and supply of the products, as regulatory compliance and patient safety are manufacturers' primary concerns.
In 2023, Germany spent USD 8,011 per capita on health, approximately 12.7% of GDP. It is also one of the largest producers and exporters of healthcare products.
Europe Healthcare Cold Chain Logistics Industry Segmentation
Healthcare cold chain logistics services involve specialized solutions for secured storage, transport, and distribution of temperature-sensitive healthcare products, such as pharmaceuticals and vaccines. These services include temperature-controlled transportation with advanced packaging, cold storage facilities, real-time monitoring for supply chain visibility, risk management, and specialized handling for biopharmaceuticals. The complete offerings ensure the efficacy of healthcare products, along with regulatory guidelines.
A comprehensive background analysis of the European healthcare cold chain logistics market covers current market trends, restraints, technological updates, and detailed information on various segments and the industry's competitive landscape. The impact of COVID-19 has also been incorporated and considered during the study.
Europe's healthcare cold chain logistics market is segmented by product (biopharmaceuticals, vaccines, and clinical trial materials), services (transportation, storage, packaging, and value-added services (packaging and labeling), end user (hospitals, clinics, and pharmaceuticals, biopharmaceutical, and biotechnology) and country (Germany, France, Italy, Spain, and Rest of Europe).The report offers market size and forecasts for the European healthcare cold chain logistics market in value (USD) for all the above segments.
| By Product | |
| Biopharmaceuticals | |
| Vaccines | |
| Clinical Trial Materials |
| By Services | |
| Transportation | |
| Storage | |
| Value Added Services (Packaging and Labeling) |
| By End User | |
| Hospitals, Clinics and Pharmaceuticals | |
| Biopharmaceutical | |
| Biotechnology |
| By Country | |
| Germany | |
| France | |
| Spain | |
| Rest of Europe |
Europe Healthcare Cold Chain Logistics Market Size Summary
The European healthcare cold chain logistics market is experiencing significant growth, driven by the increasing development and production of biopharmaceuticals, vaccines, and advanced therapies. This growth is further supported by technological advancements and a strong focus on research and development within the region. The COVID-19 pandemic highlighted the critical role of cold chain logistics in the pharmaceutical sector, as the demand for temperature-sensitive products surged. The European Medical Agency's approval of a growing number of drugs annually underscores the expanding biopharmaceutical sector, which necessitates stringent storage and supply chain requirements to ensure regulatory compliance and patient safety. The rise in health awareness and the shift towards self-care and over-the-counter pharmaceuticals, facilitated by e-commerce, have also contributed to the market's expansion. Governments across Europe are actively supporting the industry, with initiatives aimed at broadening the range of available medicines and enhancing pharmaceutical production capabilities.
The competitive landscape of the European healthcare cold chain logistics market is characterized by the presence of numerous companies, each striving to meet the high barriers to entry posed by specialized infrastructure and regulatory compliance requirements. Key players such as DHL, Kuehne + Nagel, and DB Schenker are investing in technology and expanding their global networks to maintain competitiveness. Recent strategic moves, such as UPS's acquisition of Transports (Chabas Santé) and Maersk's construction of a new cold storage facility in Rotterdam, highlight the industry's focus on enhancing temperature-controlled transportation and storage solutions. These developments are crucial for supporting the increasing demand for efficient cold chain logistics systems, as the market continues to grow in response to the rising production of pharmaceuticals and the emphasis on prevention and self-medication across Europe.
Europe Healthcare Cold Chain Logistics Market Size - Table of Contents
-
1. MARKET INSIGHTS
-
1.1 Current Market Scenario
-
1.2 Technological Trends
-
1.3 Industry Value Chain Analysis
-
1.4 Government Regulations and Initiatives
-
1.5 Spotlight on Ambient/Temperature-controlled Storage
-
1.6 Insights into Refrigerants and Packaging Materials Used in Refrigerated Warehouses
-
1.7 Impact of COVID-19 on the Market
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 Biopharmaceuticals
-
2.1.2 Vaccines
-
2.1.3 Clinical Trial Materials
-
-
2.2 By Services
-
2.2.1 Transportation
-
2.2.2 Storage
-
2.2.3 Value Added Services (Packaging and Labeling)
-
-
2.3 By End User
-
2.3.1 Hospitals, Clinics and Pharmaceuticals
-
2.3.2 Biopharmaceutical
-
2.3.3 Biotechnology
-
-
2.4 By Country
-
2.4.1 Germany
-
2.4.2 France
-
2.4.3 Spain
-
2.4.4 Rest of Europe
-
-
Europe Healthcare Cold Chain Logistics Market Size FAQs
How big is the Europe Healthcare Cold Chain Logistics Market?
The Europe Healthcare Cold Chain Logistics Market size is expected to reach USD 10.40 billion in 2024 and grow at a CAGR of 9.69% to reach USD 16.39 billion by 2029.
What is the current Europe Healthcare Cold Chain Logistics Market size?
In 2024, the Europe Healthcare Cold Chain Logistics Market size is expected to reach USD 10.40 billion.
